Loading...
•
Jun 30, 2020
Globus Medical Q2 2020 Earnings Report
Globus Medical's revenue decreased, resulting in a net loss, but non-GAAP EPS remained positive, and the company focused on strategic improvements during the second quarter.
Key Takeaways
Globus Medical reported a decrease in worldwide sales by 23.4% compared to the second quarter of 2019. The company experienced a net loss of $20.8 million, but non-GAAP diluted EPS was $0.07. Despite the challenges, Globus Medical focused on strengthening its business for future growth.
Worldwide sales decreased by 23.4% year-over-year to $148.9 million.
The company had a net loss of $20.8 million.
Diluted EPS was $(0.21), while non-GAAP diluted EPS was $0.07.
Non-GAAP adjusted EBITDA was 14.7% of sales.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Globus Medical withdrew its full year 2020 guidance due to the uncertainties related to the COVID-19 pandemic.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...